RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at two upcoming investor conferences.
- Stifel 2015 Healthcare Conference on Tuesday, November 17, 2015 at 3:00 pm Eastern Time at the Palace Hotel in New York.
- Canaccord Genuity Medical Technologies and Diagnostics Forum on Thursday, November 19, 2015 at 11:20 am Eastern Time at the Westin Grand Central in New York.
To access the live audio webcast or archived recording for either conference, use the following link http://ir.transenterix.com/events.cfm. The replay for both presentations will also be available on the company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the development and commercialization of the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform, and the commercialization of ALF-X®, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye tracking camera control. The SurgiBot System is not yet available for sale in any market. The ALF-X has been granted a CE Mark but is not available for sale in the US. For more information, visit the TransEnterix website at www.transenterix.com.
